These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20055712)

  • 1. Pseudomonas aeruginosa biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies.
    Hassett DJ; Korfhagen TR; Irvin RT; Schurr MJ; Sauer K; Lau GW; Sutton MD; Yu H; Hoiby N
    Expert Opin Ther Targets; 2010 Feb; 14(2):117-30. PubMed ID: 20055712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets.
    Hassett DJ; Cuppoletti J; Trapnell B; Lymar SV; Rowe JJ; Yoon SS; Hilliard GM; Parvatiyar K; Kamani MC; Wozniak DJ; Hwang SH; McDermott TR; Ochsner UA
    Adv Drug Deliv Rev; 2002 Dec; 54(11):1425-43. PubMed ID: 12458153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaerobic Pseudomonas aeruginosa and other obligately anaerobic bacterial biofilms growing in the thick airway mucus of chronically infected cystic fibrosis patients: an emerging paradigm or "Old Hat"?
    Su S; Hassett DJ
    Expert Opin Ther Targets; 2012 Sep; 16(9):859-73. PubMed ID: 22793158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microenvironmental characteristics and physiology of biofilms in chronic infections of CF patients are strongly affected by the host immune response.
    Jensen PØ; Kolpen M; Kragh KN; Kühl M
    APMIS; 2017 Apr; 125(4):276-288. PubMed ID: 28407427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Shear Stress on Pseudomonas aeruginosa Isolated from the Cystic Fibrosis Lung.
    Dingemans J; Monsieurs P; Yu SH; Crabbé A; Förstner KU; Malfroot A; Cornelis P; Van Houdt R
    mBio; 2016 Aug; 7(4):. PubMed ID: 27486191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
    Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
    Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms.
    Matsui H; Wagner VE; Hill DB; Schwab UE; Rogers TD; Button B; Taylor RM; Superfine R; Rubinstein M; Iglewski BH; Boucher RC
    Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18131-6. PubMed ID: 17116883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
    Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA
    J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biofilm differentiation and dispersal in mucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
    Kirov SM; Webb JS; O'May CY; Reid DW; Woo JKK; Rice SA; Kjelleberg S
    Microbiology (Reading); 2007 Oct; 153(Pt 10):3264-3274. PubMed ID: 17906126
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Brao KJ; Wille BP; Lieberman J; Ernst RK; Shirtliff ME; Harro JM
    Infect Immun; 2020 Aug; 88(9):. PubMed ID: 32631918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evolution of Pseudomonas aeruginosa AA2 biofilms in the presence of cystic fibrosis lung microbiome members.
    Vandeplassche E; Sass A; Lemarcq A; Dandekar AA; Coenye T; Crabbé A
    Sci Rep; 2019 Sep; 9(1):12859. PubMed ID: 31492943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Airway biofilms: implications for pathogenesis and therapy of respiratory tract infections.
    Kobayashi H
    Treat Respir Med; 2005; 4(4):241-53. PubMed ID: 16086598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting quorum sensing in Pseudomonas aeruginosa biofilms: current and emerging inhibitors.
    Jakobsen TH; Bjarnsholt T; Jensen PØ; Givskov M; Høiby N
    Future Microbiol; 2013 Jul; 8(7):901-21. PubMed ID: 23841636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dispersal of Epithelium-Associated Pseudomonas aeruginosa Biofilms.
    Zemke AC; D'Amico EJ; Snell EC; Torres AM; Kasturiarachi N; Bomberger JM
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32669459
    [No Abstract]   [Full Text] [Related]  

  • 15. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
    Furiga A; Lajoie B; El Hage S; Baziard G; Roques C
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1676-86. PubMed ID: 26711774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unveiling the early events of Pseudomonas aeruginosa adaptation in cystic fibrosis airway environment using a long-term in vitro maintenance.
    Sousa AM; Monteiro R; Pereira MO
    Int J Med Microbiol; 2018 Dec; 308(8):1053-1064. PubMed ID: 30377031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of bacterial biofilms in chronic infections.
    Bjarnsholt T
    APMIS Suppl; 2013 May; (136):1-51. PubMed ID: 23635385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas aeruginosa and Klebsiella pneumoniae Adaptation to Innate Immune Clearance Mechanisms in the Lung.
    Riquelme SA; Ahn D; Prince A
    J Innate Immun; 2018; 10(5-6):442-454. PubMed ID: 29617698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
    Murray TS; Egan M; Kazmierczak BI
    Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P. aeruginosa Biofilms in CF Infection.
    Wagner VE; Iglewski BH
    Clin Rev Allergy Immunol; 2008 Dec; 35(3):124-34. PubMed ID: 18509765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.